Filing
Spy
Filing
Spy
Home
About
FNCH
Finch Therapeutics Group Inc
Clinical-stage biotechnology company developing microbiome therapies
CUSIP: 31773D200
Healthcare
US
1 holder
Ownership
Activity
2023 Q4
1 of 3 quarters
Total Value
$243.0K
Total Shares
67.3K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$243.0K
67.3K
0.0%
Unchanged
Baupost Group LLC
$243.0K
67.3K shares
Unchanged
FNCH — Finch Therapeutics Group Inc - FilingSpy